Babson’s David Stein: “Succeeding where Theranos failed”
The Sunday Times’ tech correspondent Danny Fortson brings on David Stein, chief executive of Babson Diagnostics, to talk about the importance of blood testing (4:49), why Babson is not Theranos (6:47), trying to compete with that idea (9:26), why they succeeded where Theranos failed (14:34), using a tiny amount of…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Times Tech
See all episodes →
Why OpenAI and Anthropic should fear Meta Muse
The Interview: Nu Quantum CEO on how quantum computing could solve the energy crisis
The Interview: Nu Quantum CEO on how quantum computing could solve nature’s problems
Similar episodes from other shows
More like Times Tech →
A simple new blood test that can catch cancer early | Jimmy Lin
Theranos and Silicon Valley
Holmes stretch: Theranos’s founder convicted
Mary Lou Jepsen on the wearable MRI
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.